Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $12.7 Million - $15 Million
-148,302 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $10.9 Million - $14.6 Million
148,302 New
148,302 $14.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alpha Wave Global, LP Portfolio

Follow Alpha Wave Global, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Wave Global, LP, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Wave Global, LP with notifications on news.